BBC visits mpox clinic as WHO says DR Congo cases 'plateauing'
November 22, 2024
Medics in the Democratic Republic of Congo (DRC) report a decline in new mpox cases, particularly in areas where vaccination campaigns have rolled out. Over 50,000 people have been vaccinated since October, with efforts focusing on high-risk communities. While the WHO acknowledges a plateau in cases, officials warn it’s too early to declare the outbreak under control. Children remain disproportionately affected, accounting for 30% of infections, but vaccinations for this group have only recently been authorized. With over 90% of mpox deaths this year occurring in the DRC, experts stress the need for continued vigilance and a coordinated global response.
In the Democratic Republic of Congo (DRC), medics at the epicenter of the mpox outbreak report encouraging signs of progress, with new infections slowing in communities where vaccination campaigns have been implemented. Since October, more than 50,000 people have been vaccinated, following the delivery of 265,000 doses donated by the international community. Targeted efforts have focused on high-risk groups, particularly in the eastern regions. Medics in Lwiro, once overwhelmed by the influx of patients, now note significantly fewer daily cases and some empty beds in clinics that were previously overcrowded.
Despite this progress, challenges remain. Children, who represent 30% of infections in the DRC, remain disproportionately affected, yet vaccination efforts for this vulnerable group have only recently been authorized with the approval of Japan’s LC16m8 vaccine. Dr. Jean Kaseya of the Africa CDC warns that children not only suffer from the disease but also act as key vectors of transmission.
The World Health Organization (WHO) confirms a plateau in cases but cautions against premature optimism. More than 90% of global mpox deaths this year occurred in the DRC, where limited laboratory infrastructure hinders accurate reporting. Vaccination programs in neighboring countries, such as Nigeria and Rwanda, are also underway, yet the disease continues to spread globally, with cases now reported in countries including the UK, US, Sweden, and India.
WHO officials and African public health leaders stress the urgency of sustained interventions, including expanded vaccination campaigns, strengthened surveillance, and improved diagnostic systems. Dr. Samuel Boland of the WHO emphasizes that while some progress is evident, the outbreak remains a pressing global concern requiring a coordinated response. With continued efforts, experts hope to see significant reductions in cases and fatalities by early 2025.